[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100159073":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":20,"locations":20,"responsibleParty":25,"collaborators":20,"id":27,"slug":28,"hasResults":29,"nctId":30,"briefTitle":31,"officialTitle":32,"acronym":20,"eligibilityCriteria":33,"healthyVolunteers":34,"sex":35,"minAge":36,"maxAge":37,"enrollmentInfo":38,"targetDuration":20,"studyType":41,"phases":42,"briefSummary":44,"conditions":45,"keywords":47,"overallStatus":52,"whyStopped":20,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":20},{"fullName":5,"class":6},"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"001","EXPERIMENTAL","Canagliflozin Type = 1 unit = mg number = 300 form = tablet route = oral use. Single tablet taken with or without a meal during 2 treatment periods",[13],"Drug: Canagliflozin",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Canagliflozin","Type = 1, unit = mg, number = 300, form = tablet, route = oral use. Single tablet taken with or without a meal during 2 treatment periods",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial","STUDY_DIRECTOR",{"type":26,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100159073","phase-1-the-effect-of-food-on-the-administration-of-canagliflozin-in-healthy-adult-volunteers-100159073",false,"NCT01343290","The Effect of Food on the Administration of Canagliflozin in Healthy Adult Volunteers","A Single-Dose, Open-Label, Randomized, 2-Period, 2-Sequence, Crossover Study to Determine the Effect of Food Coadministration on the Pharmacokinetics of 300 mg Canagliflozin in Healthy Subjects","Inclusion Criteria:\n\n* Healthy volunteers with a body mass index between 18 and 30 kg\u002Fm2 (inclusive) and body weight not less than 50 kg\n\nExclusion Criteria:\n\n* of or current medical illness deemed clinically significant by the Investigator (study physician)",true,"ALL","18 Years","55 Years",{"count":39,"type":40},24,"ACTUAL","INTERVENTIONAL",[43],"PHASE1","The purpose of this study is to assess the effect of food on the absorption of canagliflozin in the body when canagliflozin is taken with and without food by healthy volunteers",[46],"Healthy",[48,49,50,51],"Canagliflozin (JNJ-28431754)","Pharmacokinetic","Oral Bioavailability","Food effect","COMPLETED","2012-09-29",{"date":55,"type":56},"2012-10-02","ESTIMATED",{"date":58,"type":20},"2011-04",{"date":60,"type":40},"2011-06",{"name":5,"class":6}]